Scientific Officer Jacques Turgeon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 
Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, today announces it has entered into a partnership with Tabula Rasa HealthCare® ( TRHC ) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety. Through this initiative, Physiomics personalised docetaxel model will be integrated into TRHC s market-leading precision dosing solution, DoseMeRx®. Both parties expect positive feedback from this initial trial with the next step being a commercial agreement.
 
Cancer remains one of the leading causes of death in developed countries and one of the most significant areas of spend for health systems.  There are many effective cancer drugs; but, it is well established that, given the same dose, variations between individuals mean that different amounts of drug reach their tumours. ....

United States , Jim Millen , Charles Cornish , Richard Tulloch James , Jacques Turgeon , Diannel Semingson , Strand Hanson Ltd , Merck Kga , Company Virtual Tumour , Merck Kgaa , Merck Co , Targeting Precision Dosing , Tabula Rasa Healthcare , Chief Executive Officer , Scientific Officer Jacques Turgeon , Vice President , Hospital Business Unit , Market Abuse Regulations , Hanson Ltd , Virtual Tumour , Rasa Healthcare , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் மில்லன் , சார்லஸ் கார்னிஷ் , ரிச்சர்ட் டலொக் ஜேம்ஸ் , ஜாக்ஸ் டர்ஜன் ,